Cargando…
Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
BACKGROUND: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower cardiovascular events in type 2 diabetes mellitus (T2DM) patients, although the mechanisms underlying these benefits are not clearly understood. Our aim was to study the effects of SGLT2i on left ventricular remodelling and longitu...
Autores principales: | Gamaza-Chulián, Sergio, Díaz-Retamino, Enrique, González-Testón, Fátima, Gaitero, José Carlos, Castillo, María José, Alfaro, Raquel, Rodríguez, Elías, González-Caballero, Eva, Martín-Santana, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456580/ https://www.ncbi.nlm.nih.gov/pubmed/34548011 http://dx.doi.org/10.1186/s12872-021-02250-9 |
Ejemplares similares
-
An alternative method of indexation in aortic stenosis: height-adjusted effective orifice area: An observational prospective study
por: Gamaza-Chulián, Sergio, et al.
Publicado: (2023) -
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
por: Cherney, David, et al.
Publicado: (2017) -
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
por: Simes, Bryce C, et al.
Publicado: (2019) -
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
por: Jasleen, Bains, et al.
Publicado: (2023) -
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
por: Andreea, Munteanu Madalina, et al.
Publicado: (2023)